```html

Port‑Wine Stains (Nevus Flammeus)

What is Port‑wine stains?

Port‑wine stains, also called nevus flammeus, are flat, pink‑to‑deep‑purple birthmarks that result from an over‑abundance of dilated capillaries (tiny blood vessels) in the skin’s superficial dermis. The name comes from the lesion’s resemblance to the reddish‑purple color of a glass of port wine. These marks are present at birth, persist throughout life, and most often appear on the face, neck, scalp, arms, or legs.

Unlike many other birthmarks, port‑wine stains do not fade spontaneously. If left untreated, they may darken, thicken, and develop a textured, “cobblestone” surface during adolescence or adulthood. While the stain itself is benign, it can be a clue to underlying vascular or neuro‑cutaneous syndromes that require medical attention.

Common Causes

Port‑wine stains are not caused by a single disease; they are a manifestation of abnormal vascular development in utero. The following conditions are most frequently associated with or can present with port‑wine stains:

• Isolated (sporadic) nevus flammeus – the classic, solitary birthmark without other systemic findings.
• Sturge‑Weber syndrome (SWS) – a neuro‑cutaneous disorder that includes facial port‑wine stains, leptomeningeal angiomas, and glaucoma.
• Klippel‑Trénaunay syndrome (KTS) – a triad of port‑wine stain, varicose veins, and soft‑tissue/bone overgrowth.
• Parkes‑Weber syndrome – similar to KTS but with high‑flow arteriovenous malformations (AVMs) causing pulsatile lesions.
• Barlow’s disease (pseudoglycogen storage disease) – rare; can show extensive cutaneous vascular lesions.
• Hereditary hemorrhagic telangiectasia (HHT) – while telangiectasias are more typical, some patients display port‑wine stains overlying AVMs.
• Congenital hemangioma – a true vascular tumor that may coexist with a port‑wine stain‑like background.
• Phakomatosis pigmentovascularis – a group of disorders where a pigmentary nevus is paired with a vascular birthmark such as a port‑wine stain.
• Neurofibromatosis type 1 (NF1) – occasionally associated with focal vascular anomalies that resemble port‑wine stains.
• Rendu‑Osler‑Weber disease – may show extensive cutaneous vascular malformations that can be misinterpreted as port‑wine stains.

Associated Symptoms

Port‑wine stains themselves are painless, but many patients experience additional findings, especially when the stain is part of a syndrome.

• Glaucoma or ocular hypertension – common in Sturge‑Weber syndrome when the stain involves the upper eyelid or forehead.
• Seizures or developmental delay – related to leptomeningeal angiomas in SWS.
• Facial asymmetry or bony overgrowth – seen in KTS and Parkes‑Weber.
• Frequent nosebleeds (epistaxis) or GI bleeding – can accompany HHT.
• Pain or throbbing sensation – may develop as the lesion thickens or if underlying AVMs are present.
• Skin changes over time – darkening, hypertrophy, or development of nodular lesions.
• Psychosocial impact – cosmetic concerns, low self‑esteem, or bullying especially in children.

When to See a Doctor

Most isolated port‑wine stains are harmless, but you should seek professional evaluation promptly if any of the following occur:

• Rapid darkening or thickening of the lesion after infancy.
• New onset of pain, throbbing, or warmth in the area.
• Development of a raised, nodular, or ulcerated surface.
• Visual disturbances, eye redness, or a diagnosis of glaucoma.
• Seizures, unexplained headaches, or developmental regression.
• Swelling, varicose veins, or limb length discrepancy near the stain.
• Any bleeding that does not stop with gentle pressure.

Early referral to a dermatologist, pediatrician, or neurologist can help identify an underlying syndrome and prevent complications.

Diagnosis

Diagnosing a port‑wine stain involves a combination of clinical examination and, when indicated, imaging studies.

Clinical Evaluation

• History – birth history, progression of the lesion, family history of vascular anomalies, and any neurologic or ophthalmologic symptoms.
• Physical exam – assessment of the size, color, borders, texture, and location; evaluation for associated signs such as facial asymmetry, limb overgrowth, or ocular involvement.

Imaging & Tests (when needed)

• Doppler ultrasound – distinguishes low‑flow capillary malformations (typical port‑wine stains) from high‑flow AVMs.
• Magnetic Resonance Imaging (MRI) or MR angiography – used when neurologic involvement is suspected (e.g., Sturge‑Weber). Shows leptomeningeal angiomas or brain dysplasia.
• CT scan of the head – may demonstrate calcifications (“tram‑track” sign) in SWS.
• Ophthalmologic exam – intra‑ocular pressure measurement and slit‑lamp exam for glaucoma.
• Genetic testing – panel for GNAQ mutation (found in many isolated port‑wine stains) or for RASA1, PIK3CA, and other genes when a syndrome is suspected.

Treatment Options

Management focuses on improving cosmetic appearance, preventing progression, and addressing any associated complications.

Laser Therapy

• Pulsed‑dye laser (PDL) – the gold‑standard first‑line treatment; targets oxyhemoglobin, reducing redness and pigment depth. Multiple sessions (typically 4‑8) spaced 6‑8 weeks apart are required.
• Nd:YAG laser – penetrates deeper; useful for thicker, darker stains or those unresponsive to PDL.
• Intense pulsed light (IPL) – offers broader wavelength coverage; may be combined with PDL for better results in some patients.
• **Efficacy** – 50‑80 % reduction in color intensity is common; results are durable but maintenance sessions may be needed.

Medical & Surgical Options

• Topical agents – limited data; beta‑blocker creams (e.g., timolol) have been explored for infantile hemangiomas but are not standard for port‑wine stains.
• Photodynamic therapy (PDT) – experimental; involves a photosensitizing drug activated by light to ablate abnormal vessels.
• Radiofrequency ablation / Cryotherapy – reserved for localized nodular lesions.
• Surgical excision – rarely indicated; may be considered for small, focal lesions that are refractory to laser and cause functional problems.

Management of Associated Conditions

• Glaucoma – topical pressure‑lowering drops, laser trabeculoplasty, or surgery as directed by an ophthalmologist.
• Seizure control – antiepileptic medications, neurosurgical evaluation for cortical resection if indicated.
• Vascular malformations (AVMs) – embolization or surgical removal performed by an interventional radiologist or vascular surgeon.

Supportive Care

• Psychological counseling or support groups for children and adults dealing with cosmetic concerns.
• Sunscreen (SPF 30 or higher) to protect the lesion from UV‑induced darkening.
• Gentle skin care; avoid harsh scrubbing or abrasive products that could irritate the area.

Prevention Tips

Because port‑wine stains are congenital, true prevention is not possible. However, steps can be taken to limit progression and complications:

• Early laser referral – initiating treatment before the lesion thickens (ideally before age 1‑2) yields the best cosmetic outcome.
• Sun protection – daily sunscreen and protective clothing reduce hyperpigmentation.
• Avoid trauma – bruising or repeated friction can cause inflammation and darkening.
• Regular ophthalmology checks – especially when the stain involves the forehead or eyelid.
• Routine monitoring – schedule annual skin examinations for changes in size, color, or texture.
• Genetic counseling – recommended for families with known syndromic associations (e.g., Sturge‑Weber) to discuss recurrence risk.

Emergency Warning Signs

If any of the following acute symptoms appear, seek emergency medical care (or call 911):

• Sudden, severe pain or throbbing in the stained area.
• Rapid swelling or sudden enlargement of the lesion.
• Uncontrolled bleeding that does not stop with pressure.
• Acute vision loss, eye pain, or sudden increase in eye pressure.
• New onset seizure, loss of consciousness, or severe headache.
• Fever, redness, or pus suggestive of infection of the skin overlying the stain.

Key Take‑aways

Port‑wine stains are common vascular birthmarks that can be isolated or part of complex syndromes. While the lesions themselves are benign, they may signal deeper neurologic or ocular issues that need prompt attention. Early laser therapy, vigilant monitoring, and management of any associated complications provide the best outcomes. Patients and caregivers should stay aware of warning signs that warrant urgent evaluation.

Sources: Mayo Clinic, American Academy of Dermatology, National Institute of Neurological Disorders and Stroke (NINDS), Sturge‑Weber Syndrome Foundation, Cleveland Clinic, Journal of Clinical Dermatology (2022), WHO Classification of Vascular Anomalies (2023).

```